Posted inMedical Technology
Danaher buys patient monitoring specialist Masimo in $9.9B deal
Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio.…
Posted inMedical Technology
Novocure gets FDA nod for tumor-treating electric fields targeting pancreatic cancer
The FDA gave the go-ahead to Novocure for its tumor-treating electric fields device that targets advanced pancreatic cancer in conjunction…
Posted inMedical Technology
FDA clears Encora Therapeutics’ wearable wrist device for essential tremor
For millions of Americans with essential tremor, simple tasks like writing a note, putting on makeup or plugging in an…
Posted inMedical Technology
Integra LifeSciences cuts roles as 65 staffers impacted from Princeton, N.J., site
One month after Integra LifeSciences recalled its wound and burn devices amid safety concerns, the medtech company is cutting jobs…
Posted inMedical Technology
Labcorp launches Roche’s FDA-cleared Alzheimer’s blood test
Labcorp is now offering Roche Diagnostics' recently FDA-cleared Alzheimer’s disease blood test to help primary care doctors rule out the…
Posted inMedical Technology
Agilent companion diagnostic lands FDA nod alongside Keytruda’s latest cancer approval
As Merck received its latest FDA nod for Keytruda in ovarian cancer, Agilent gained the green light for its accompanying…
Posted inMedical Technology
GE HealthCare debuts tech to help hospitals remotely maintain bedside ECG stations
GE HealthCare has launched a new technology designed to help hospitals keep up with the maintenance and repair demands of…
Posted inMedical Technology
Merck teams up with British medtech to boost vaginal therapeutics delivery system
German Merck has set up a new collaboration with U.K. medtech company Calla Lily Clinical Care to work on its…
Posted inMedical Technology
FDA slaps highest-risk recall notice on J&J Medtech Cerepak detachable coils
The FDA has flagged J&J Medtech’s recall of its Cerepak detachable coils as Class I in the wake of one…
Posted inMedical Technology
Qiagen ‘open for discussion’ on shareholder value, but CEO stays mum on takeover talk
Qiagen’s outgoing chief executive Thierry Bernard, M.D., told investors the company does not “comment on rumors” as takeover talks swirl…